Júlia Companys‐Alemany

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease”.

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease

Neurotherapeutics(2020)10.1007/s13311-020-00854-1

N/A

0DataRank · unranked

88 citations

Sandra Codony, Eugènia Pujol, Jun Yang, Rosana Leiva, Carmen Escolano +13 more

Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents

ChemMedChem(2022)10.1002/cmdc.202200002

N/A

0DataRank · unranked

12 citations

Bhanwar Singh Choudhary, Júlia Companys‐Alemany, Sukanya Sukanya, Pedro Antonio Ávila-López, Antón L. Martínez +6 more

Uncovering the role of G9a modulatory landscape promoting neuronal plasticity and neuroprotection in Alzheimer's disease

Research Square(2022)10.21203/rs.3.rs-1228952/v1

N/A

0DataRank · unranked

0 citations

Pedro Antonio Ávila-López, Júlia Companys‐Alemany, Gemma Navarro, Laura Marsal-García, Raquel Larramona‐Arcas +8 more

G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease

Aging and Disease(2024)10.14336/ad.2023.0424-2

N/A

0DataRank · unranked

22 citations

Qizhi Geng, Gemma Navarro, Pedro Antonio Ávila-López, Júlia Companys‐Alemany, Laura Marsal-García +12 more